
### [NCIT:C3234](http://purl.obolibrary.org/obo/NCIT_C3234)
**Label:** Mesothelioma

**Subclasses:** [NCIT:C3765](http://purl.obolibrary.org/obo/NCIT_C3765) (Multicystic Mesothelioma), [NCIT:C136399](http://purl.obolibrary.org/obo/NCIT_C136399) (Pleural Malignant Mesothelioma by AJCC v8 Stage), [NCIT:C3762](http://purl.obolibrary.org/obo/NCIT_C3762) (Adenomatoid Tumor), [NCIT:C7985](http://purl.obolibrary.org/obo/NCIT_C7985) (Epithelioid Mesothelioma), [NCIT:C4499](http://purl.obolibrary.org/obo/NCIT_C4499) (Pleural Adenomatoid Tumor), [NCIT:C45661](http://purl.obolibrary.org/obo/NCIT_C45661) (Peritoneal Well Differentiated Papillary Mesothelioma), [NCIT:C6536](http://purl.obolibrary.org/obo/NCIT_C6536) (Peritoneal Multicystic Mesothelioma), [NCIT:C4456](http://purl.obolibrary.org/obo/NCIT_C4456) (Malignant Mesothelioma), [NCIT:C45660](http://purl.obolibrary.org/obo/NCIT_C45660) (Pleural Well Differentiated Papillary Mesothelioma), [NCIT:C7866](http://purl.obolibrary.org/obo/NCIT_C7866) (Recurrent Malignant Mesothelioma), [NCIT:C45663](http://purl.obolibrary.org/obo/NCIT_C45663) (Pleural Sarcomatoid Mesothelioma), [NCIT:C45662](http://purl.obolibrary.org/obo/NCIT_C45662) (Pleural Epithelioid Mesothelioma), [NCIT:C45665](http://purl.obolibrary.org/obo/NCIT_C45665) (Pleural Biphasic Mesothelioma), [NCIT:C45664](http://purl.obolibrary.org/obo/NCIT_C45664) (Pleural Desmoplastic Mesothelioma), [NCIT:C48319](http://purl.obolibrary.org/obo/NCIT_C48319) (Adrenal Gland Adenomatoid Tumor), [NCIT:C40129](http://purl.obolibrary.org/obo/NCIT_C40129) (Fallopian Tube Adenomatoid Tumor), [NCIT:C45666](http://purl.obolibrary.org/obo/NCIT_C45666) (Localized Pleural Malignant Mesothelioma), [NCIT:C136374](http://purl.obolibrary.org/obo/NCIT_C136374) (Pleural Malignant Mesothelioma by AJCC v7 Stage), [NCIT:C9350](http://purl.obolibrary.org/obo/NCIT_C9350) (Peritoneal Malignant Mesothelioma), [NCIT:C9351](http://purl.obolibrary.org/obo/NCIT_C9351) (Pleural Mesothelioma), [NCIT:C40444](http://purl.obolibrary.org/obo/NCIT_C40444) (Ovarian Malignant Mesothelioma), [NCIT:C6747](http://purl.obolibrary.org/obo/NCIT_C6747) (Desmoplastic Mesothelioma), [NCIT:C6648](http://purl.obolibrary.org/obo/NCIT_C6648) (Stage III Pleural Malignant Mesothelioma AJCC v7), [NCIT:C136403](http://purl.obolibrary.org/obo/NCIT_C136403) (Stage III Pleural Malignant Mesothelioma AJCC v8), [NCIT:C8707](http://purl.obolibrary.org/obo/NCIT_C8707) (Recurrent Pleural Malignant Mesothelioma), [NCIT:C6647](http://purl.obolibrary.org/obo/NCIT_C6647) (Stage II Pleural Malignant Mesothelioma AJCC v7), [NCIT:C8705](http://purl.obolibrary.org/obo/NCIT_C8705) (Recurrent Peritoneal Malignant Mesothelioma), [NCIT:C136406](http://purl.obolibrary.org/obo/NCIT_C136406) (Stage IV Pleural Malignant Mesothelioma AJCC v8), [NCIT:C6649](http://purl.obolibrary.org/obo/NCIT_C6649) (Stage IV Pleural Malignant Mesothelioma AJCC v7), [NCIT:C7633](http://purl.obolibrary.org/obo/NCIT_C7633) (Peritoneal Mesothelioma), [NCIT:C136400](http://purl.obolibrary.org/obo/NCIT_C136400) (Stage I Pleural Malignant Mesothelioma AJCC v8), [NCIT:C6646](http://purl.obolibrary.org/obo/NCIT_C6646) (Stage I Pleural Malignant Mesothelioma AJCC v7), [NCIT:C9239](http://purl.obolibrary.org/obo/NCIT_C9239) (Localized Malignant Mesothelioma), [NCIT:C7635](http://purl.obolibrary.org/obo/NCIT_C7635) (Well Differentiated Papillary Mesothelioma), [NCIT:C136402](http://purl.obolibrary.org/obo/NCIT_C136402) (Stage II Pleural Malignant Mesothelioma AJCC v8), [NCIT:C92187](http://purl.obolibrary.org/obo/NCIT_C92187) (Pericardial Adenomatoid Tumor), [NCIT:C7354](http://purl.obolibrary.org/obo/NCIT_C7354) (Peritoneal Adenomatoid Tumor), [NCIT:C27926](http://purl.obolibrary.org/obo/NCIT_C27926) (Asbestos-Related Malignant Mesothelioma), [NCIT:C7376](http://purl.obolibrary.org/obo/NCIT_C7376) (Pleural Malignant Mesothelioma), [NCIT:C7632](http://purl.obolibrary.org/obo/NCIT_C7632) (Pericardial Mesothelioma), [NCIT:C7631](http://purl.obolibrary.org/obo/NCIT_C7631) (Pericardial Malignant Mesothelioma), [NCIT:C45655](http://purl.obolibrary.org/obo/NCIT_C45655) (Sarcomatoid Mesothelioma), [NCIT:C6382](http://purl.obolibrary.org/obo/NCIT_C6382) (Epididymal Adenomatoid Tumor), [NCIT:C4282](http://purl.obolibrary.org/obo/NCIT_C4282) (Biphasic Mesothelioma), [NCIT:C8420](http://purl.obolibrary.org/obo/NCIT_C8420) (Diffuse Malignant Mesothelioma), [NCIT:C9253](http://purl.obolibrary.org/obo/NCIT_C9253) (Recurrent Pericardial Malignant Mesothelioma), [NCIT:C126331](http://purl.obolibrary.org/obo/NCIT_C126331) (Ovarian Adenomatoid Tumor), [NCIT:C27250](http://purl.obolibrary.org/obo/NCIT_C27250) (Uterine Corpus Adenomatoid Tumor), 

**Class expressions from DL-Learner:**

- Thing 55.28%
- [NCIT:C36831](http://purl.obolibrary.org/obo/NCIT_C36831) (Malignant Mesothelial Cell) 53.70%
- [NCIT:C12917](http://purl.obolibrary.org/obo/NCIT_C12917) (Malignant Cell) and [NCIT:C41605](http://purl.obolibrary.org/obo/NCIT_C41605) (Neoplastic Mesothelial Cell) 53.70%
- [NCIT:C41605](http://purl.obolibrary.org/obo/NCIT_C41605) (Neoplastic Mesothelial Cell) 52.13%
- [NCIT:C36829](http://purl.obolibrary.org/obo/NCIT_C36829) (Abnormal Mesothelial Cell) 52.13%
- [NCIT:C41605](http://purl.obolibrary.org/obo/NCIT_C41605) (Neoplastic Mesothelial Cell) and (not ([NCIT:C38362](http://purl.obolibrary.org/obo/NCIT_C38362) (RUNX1 Gene Mutation))) 52.13%
- [NCIT:C41605](http://purl.obolibrary.org/obo/NCIT_C41605) (Neoplastic Mesothelial Cell) and (not ([NCIT:C3836](http://purl.obolibrary.org/obo/NCIT_C3836) (Infertility))) 52.13%
- [NCIT:C41605](http://purl.obolibrary.org/obo/NCIT_C41605) (Neoplastic Mesothelial Cell) and (not ([NCIT:C38350](http://purl.obolibrary.org/obo/NCIT_C38350) (del(4)(q12)))) 52.13%
- [NCIT:C41605](http://purl.obolibrary.org/obo/NCIT_C41605) (Neoplastic Mesothelial Cell) and (not ([NCIT:C38348](http://purl.obolibrary.org/obo/NCIT_C38348) (MSN-ALK Fusion Protein Expression))) 52.13%
- [NCIT:C41605](http://purl.obolibrary.org/obo/NCIT_C41605) (Neoplastic Mesothelial Cell) and (not ([NCIT:C38347](http://purl.obolibrary.org/obo/NCIT_C38347) (P13K-AKT Pathway Deregulation))) 52.13%
- [NCIT:C41605](http://purl.obolibrary.org/obo/NCIT_C41605) (Neoplastic Mesothelial Cell) and (not ([NCIT:C38346](http://purl.obolibrary.org/obo/NCIT_C38346) (MYC Pathway Deregulation))) 52.13%
- [NCIT:C41605](http://purl.obolibrary.org/obo/NCIT_C41605) (Neoplastic Mesothelial Cell) and (not ([NCIT:C38345](http://purl.obolibrary.org/obo/NCIT_C38345) (JUN Pathway Deregulation))) 52.13%
- [NCIT:C41605](http://purl.obolibrary.org/obo/NCIT_C41605) (Neoplastic Mesothelial Cell) and (not ([NCIT:C38344](http://purl.obolibrary.org/obo/NCIT_C38344) (RAS-RAF Pathway Deregulation))) 52.13%
- [NCIT:C41605](http://purl.obolibrary.org/obo/NCIT_C41605) (Neoplastic Mesothelial Cell) and (not ([NCIT:C38343](http://purl.obolibrary.org/obo/NCIT_C38343) (JAK-STAT Pathway Deregulation))) 52.13%
- [NCIT:C41605](http://purl.obolibrary.org/obo/NCIT_C41605) (Neoplastic Mesothelial Cell) and (not ([NCIT:C38341](http://purl.obolibrary.org/obo/NCIT_C38341) (Postgerminal Center B-Lymphocyte of Unknown Differentiation Stage))) 52.13%


